There doesn't seem to be any publicly available news. I'd be very interested to know how the investigation reported in the AFR into insolvent trading and breach of disclosure rules is going.
On the distantly related Kallium front, the deal with Reward seems to have either fallen through or will only proceed at a greatly reduced price because Reward hasn't been able to raise the funds to complete the purchase. Even at the original $20 million price tag there would have been nothing left for KLL holders. Benelong Capital Partners (BCP) has offered to take over the shell of the holding company with a consolidation of 40:1 and issue of new shares to BCP. leaving existing KLL holders with a 5% stake in the shell. That means their capital losses will be frozen indefinitely unless the shell is refloated.
If the same or similar happens here, we could be stuck with our unrealised SO4 losses (and shares) for a very, very, very long time...
- Forums
- ASX - By Stock
- SO4
- Class action *registration*
Class action *registration*, page-34
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SO4 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online